研究园简易版 · 经典书籍 · 期刊文章 · 有原文 · 完整版(可多选筛选、搜索) · 首页
2026 年的期刊文章
共 1756 篇,按发表时间排,新的在前,每页 40 篇。这一页是 2026-11-14 到 2026-11-04。
按期刊看(展开)
- JASA Journal of the American Statistical Association · 325 篇
- AoS Annals of Statistics · 111 篇
- JRSSB Journal of the Royal Statistical Society Series B · 101 篇
- JRSSA Journal of the Royal Statistical Society Series A · 67 篇
- JRSSC Journal of the Royal Statistical Society Series C · 27 篇
- Biometrika Biometrika · 73 篇
- Biometrics Biometrics · 172 篇
- SiM Statistics in Medicine · 428 篇
- SMMR Statistical Methods in Medical Research · 138 篇
- JSSAM Journal of Survey Statistics and Methodology · 5 篇
- TAS The American Statistician · 1 篇
- JMLR Journal of Machine Learning Research · 240 篇
- Econometrica Econometrica · 68 篇
按主题看(展开)
SiM Survival Analysis Machine Learning Diagnostics & Prediction · 发表于 2026-11-14
Vladimir Svetnik, Matteo Sesia, Michael Johnson, Peining Tao, Mehmet Burcu
摘要
Life‐expectancy eligibility criteria appear in approximately one quarter of oncology trials but typically rely on subjective clinician judgment and cannot be replicated in retrospective electronic health record studies. Survival prediction models provide a natural basis for objective, data‐driven operationalization of such criteria, but their practical use is complicated by four challenges: Possible model miscalibration; the need to quantify uncertainty, including about the realized operating characteristics in a random future cohort; the need to support flexible selection of the model and screening threshold by a clinician after inspecting the data; and the right‐censoring intrinsic to retrospective survival data. We propose a bootstrap‐based method that addresses all four challenges using an independent, right‐censored calibration dataset from the target population. It constructs confidence and prediction bands for cohort yield and positive predictive value as functions of the screening threshold, jointly valid over any desired collection of models and thresholds, and therefore compatible with exploratory, clinician‐driven analysis. The method is model‐agnostic, treating each survival model as an arbitrary black box without requiring it to be well calibrated. We apply it to data from over 47 000 patients with advanced non‐small cell lung cancer from the Flatiron Health Research Database, across different survival models and prediction horizons, and find that it yields stable and interpretable screening rules with reliable uncertainty quantification for future cohort‐level performance.
SiM Clinical Trials Bayesian Methods · 发表于 2026-11-13
Han Chang Chiam, Franz König, Martin Posch
摘要
Hybrid randomized controlled trials (hybrid RCTs) integrate external control data, such as historical or concurrent data, with data from randomized trials. While numerous frequentist and Bayesian methods, such as the test‐then‐pool and the meta‐analytic‐predictive prior, have been developed to account for potential disagreement between the external control and randomized data, they cannot ensure strict Type I error rate control. However, these methods can reduce biases stemming from systematic differences between external controls and trial data. A critical yet underexplored issue in hybrid RCTs is the prespecification of external data to be used in the analysis. The validity of statistical conclusions in hybrid RCTs depends on the assumption that external control selection is independent of historical trial outcomes. In practice, historical data may be accessible during the planning stage, potentially influencing important decisions, such as which historical datasets to include or the sample size of the prospective part of the hybrid trial, thus introducing bias. Such data‐driven design choices can be an additional source of bias, which can occur even when historical and prospective controls are exchangeable. Through a simulation study, we quantify the bias introduced by outcome‐dependent selection of historical controls in hybrid RCTs using both Bayesian and frequentist approaches, and discuss potential strategies to mitigate this bias. Our scenarios consider variability and time trends in the historical studies, distributional shifts between historical and prospective control groups, sample sizes and allocation ratios, as well as the number of studies included. The impact of different hypothetical selection mechanisms for selecting external controls is demonstrated using a clinical trial example.
Biometrika Testing & Uncertainty · 发表于 2026-11-13
Rohan Hore, Aaditya Ramdas
摘要
We study the problem of offline changepoint localization in a distribution-free setting. One observes a vector of data with a single changepoint, assuming that the data before and after the changepoint are i.i.d. (or more generally exchangeable) from arbitrary and unknown distributions. The goal is to produce a finite-sample confidence set for the index at which the change occurs without making any other assumptions. Existing methods often rely on parametric assumptions, tail conditions, or asymptotic approximations, or only produce point estimates. In contrast, our distribution-free algorithm, CONformal CHangepoint localization (CONCH), only leverages exchangeability arguments to construct confidence sets with finite sample coverage. By proving a conformal Neyman–Pearson lemma, we derive principled score functions that yield informative (small) sets. Moreover, with such score functions, the normalized length of the confidence set shrinks to zero under weak assumptions. We also establish a universality result showing that any distribution-free changepoint localization method must be an instance of CONCH. Experiments suggest that CONCH delivers precise confidence sets even in challenging settings involving images or text.
SMMR Clinical Trials · 发表于 2026-11-12
Jijia Wang, Song Zhang, Chul Ahn
摘要
The pre- and post-intervention design is frequently utilized in medical and behavioral research, with each subject typically providing a pair of observations collected before and after the intervention. However, not all subjects furnish complete pairs of data. Some subjects may contribute either pre- or post-intervention information only. In this study, we proposed a sample size formula based on the generalized estimating equation (GEE) method for clinical trials where subjects are supposed to provide pre- and post-intervention measurements of a count outcome. The sample size formula is flexible to accommodate different missing patterns, magnitude of missingness and correlation. We compared it with the crude sample size adjustment approach for missing data, which is commonly used in practice and involves dividing the required sample size under complete observations by the proportion of subjects with complete data. Through simulation studies, we evaluated the empirical performance of the proposed sample size formula in preserving desired power and type I error. Furthermore, we presented a clinical trial example to demonstrate its application.
SiM Missing Data & Measurement Error Meta-Analysis & Data Integration High-Dimensional · 发表于 2026-11-11
Kaida Cai, Zhengyan Wang, Hanning Chen, Hanwen Liu
摘要
Gene expression studies typically involve small sample sizes, high‐dimensional covariates, and measurement error, posing significant challenges for accurate statistical modeling. We propose simulation–extrapolation (SIMEX)–based high‐dimensional transfer learning methods (SIMEX–Trans) that (i) correct measurement error and (ii) leverage information from informative auxiliary studies. We consider settings where the informative auxiliary studies are either known or unknown, and develop Lasso‐ and SCAD‐penalized estimators. When the informative studies are known, we establish support recovery and asymptotic normality for the SIMEX‐based SCAD‐penalized estimator. Simulation results show that SIMEX–Trans outperforms competing methods in estimation accuracy and achieves reliable variable selection performance. In a GTEx brain‐tissue analysis of cross‐tissue prediction of hypothalamus JAM2 expression with limited target samples and heterogeneous auxiliary tissues, the proposed SIMEX–Trans–Selector approach achieves the lowest cross‐validated prediction error and remains stable under sensitivity analysis.
Biometrics Spatial & Time Series Genetics & Omics Latent Variables & Mixtures · 发表于 2026-11-11
Francesco Denti, Cecilia Balocchi, Vanna Denti, Giulia Capitoli
摘要
Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry Imaging (MSI) is a powerful technique for spatially resolved molecular profiling and cancer biomarker discovery. Recent advances, including a novel multiomics workflow, enable multiple rounds of MSI on the same tissue section, extracting diverse molecular classes, such as lipids, N-glycans, and peptides, while preserving spatial resolution. This innovation is particularly valuable for studies with limited tissue sample availability, such as rare diseases or small tumors. However, the resulting data are high-dimensional and spatially structured, with the various molecular types sharing the same pixel grid. To address these challenges, we propose Poseidon, a Bayesian nonparametric nested biclustering model that simultaneously segments the common tissue pixels and clusters molecular signals within each molecular class, leveraging the shared spatial structure. A separately exchangeable framework is first considered, and then extended to handle spatial data via Markov random fields. For scalability, we implement an efficient mean-field variational inference algorithm tailored for multi-dataset analysis. After validating the efficacy of our method on simulated scenarios, we demonstrate its applicability in a real-world case study, where multiomics measurements were performed on kidney tissue affected by clear cell renal cell carcinoma. The nested, hierarchical structure of Poseidon, combined with its principled inferential framework, allows the extraction of meaningful biological insights, such as clear tissue segmentation and biomarker detection.
SiM Genetics & Omics Causal Inference · 发表于 2026-11-11
Song Zhai, Bin Guo, Judong Shen
摘要
Multi‐trait Polygenic Risk Score (mtPRS) methods improve prediction accuracy compared to single‐trait PRS (stPRS) by integrating genetically correlated traits. Current mtPRS methods primarily use three approaches: (1) aggregating genome‐wide association studies (GWAS) summary statistics; (2) combining individual PRSs with weights from Principal Component Analysis (PCA); or (3) combining individual PRSs with multivariate or penalized regression‐derived weights. However, existing mtPRS methods face two main challenges: (1) selected variants are often non‐causal, lowering prediction power; and (2) no method is universally superior across diverse genetic architectures and multi‐trait correlation structures. To improve prediction performance and robustness, we propose mtPRS‐FIMEL (multi‐trait Polygenic Risk Score using FIne‐Mapping and Ensemble Learning), an ensemble learning approach that integrates fine‐mapping with multi‐trait PRS construction. mtPRS‐FIMEL computes mtPRS by combining multiple complementary mtPRS and stPRS methods and strategically leveraging causal variants identified through fine‐mapping analysis. Specifically, it uses GWAS summary statistics to estimate causal effects and learn optimal weights for a set of PRSs from complementary mtPRS (including mtPRS‐PCA, a PCA based method, and mtPRS‐ML, an elastic‐net based machine learning method, and stPRS). Our extensive simulations demonstrate that mtPRS‐FIMEL outperforms existing mtPRS and stPRS methods in terms of prediction accuracy, PRS association strength, and patient stratification performance in the simulation settings examined. Validation with PGx GWAS data from a randomized clinical trial successfully predicted the drug response of low‐density lipoprotein cholesterol (LDL‐C) change from baseline, while integrating three LDL‐C‐related traits (LDL, HDL, and Triglycerides) from disease GWAS, confirming its promising performance and robustness via a proof‐of‐concept internally cross‐validated approach.
JASA Optimization & Learning Theory · 发表于 2026-11-11
Yuanzhi Li, Shushu Zhang, Xuming He
摘要
To provide a comprehensive summary of the tail distribution, the expected shortfall is defined as the average over the tail above (or below) a certain quantile of the distribution. The expected shortfall regression captures the heterogeneous covariate-response relationship and describes the covariate effects on the tail of the response distribution. Based on a critical observation that the superquantile regression from the operations research literature does not coincide with the expected shortfall regression, we propose and validate a novel optimization-based approach for the linear expected shortfall regression, without additional assumptions on the conditional quantile models. While the proposed loss function is implicitly defined, we provide a prototype implementation of the proposed approach with some initial expected shortfall estimators based on binning techniques. With practically feasible initial estimators, we establish the consistency and the asymptotic normality of the proposed estimator. The proposed approach achieves heterogeneity-adaptive weights and therefore often offers efficiency gain over existing linear expected shortfall regression approaches in the literature, as demonstrated through simulation studies. *(abstract via OpenAlex)*
Biometrics Causal Inference · 发表于 2026-11-11
Allison Codi, Elizabeth T Rogawski McQuade, Razieh Nabi, Mats J Stensrud, Kaeum Choi, David Benkeser
摘要
Understanding vaccine effects on post-infection outcomes is critical for evaluating the full value proposition of a vaccine. However, defining appropriate causal effects on such outcomes is challenging because infection is affected by vaccination. Existing approaches focus on the Doomed stratum, individuals who would be infected regardless of vaccine receipt. For many relevant outcomes, however, this estimand understates vaccine benefit by excluding individuals whose adverse post-infection outcomes improve because vaccination prevented infection. We therefore propose causal estimands for post-infection outcomes in the Naturally Infected, individuals who would be infected in the absence of vaccine. We derive bounds under minimal assumptions and give point identification results under an exclusion restriction and/or a partial principal ignorability assumption. For point-identified settings, we develop efficient one-step estimators with robustness properties under inconsistent nuisance parameter estimation. We further show under what conditions the same identification functional can be interpreted as targeting an effect among individuals exposed to a sufficiently infectious dose of the pathogen, thereby avoiding reliance on cross-world parameters and fundamentally untestable causal assumptions. Simulations show that the bounds are valid but often wide, and that the point estimators perform well when their identifying assumptions hold. In a reanalysis of a rotavirus vaccine trial, marginal and Doomed-stratum analyses showed little evidence of an effect on antibiotic use, whereas analyses targeting the Naturally Infected suggested a protective effect under principal ignorability-based assumptions.
SiM Clinical Trials Latent Variables & Mixtures · 发表于 2026-11-10
R. E. A. Walwyn, R. A. Bailey, A. Singh, N. Corrigan, S. G. Gilmour
摘要
It is recognized that treatment‐related clustering should be allowed for in the sample size and analyses of individually‐randomized parallel‐arm trials that evaluate therapist‐delivered interventions such as psychotherapy. Here, interventions are a treatment factor, but therapists are not. If the aim of a trial is to separate effects of therapists from those of interventions, we propose that interventions and therapists should be regarded as two potentially interacting treatment factors (one fixed and one random) with a factorial structure. We consider the specific design where each therapist delivers each intervention (crossed therapist‐intervention design), and the resulting therapist‐intervention combinations are randomized to patients. We adopt a classical Design of Experiments (DoE) approach to propose a family of orthogonal factorial designs and their associated data analyses, which allow for therapist learning and center too. We set out the associated data analyses using ANOVA and regression and report the results of a small simulation study conducted to explore the performance of the proposed randomization methods in estimating the intervention effect and its standard error, the between‐therapist variance and the between‐therapist variance in the intervention effect. We conclude that more purposeful trial design has the potential to lead to better evidence on a range of complex interventions and outline areas for further methodological research.
SMMR Causal Inference · 发表于 2026-11-10
Zijian Sui, Min Zeng, Hong Zhang
摘要
Exposure mismeasurement is commonly seen in causal inference based on observational data. Recent evidence suggests that 35%–61% of medical studies using diagnostic tools report non-negligible exposure mismeasurement. For example, in the Global Enteric Multicenter Study, enzyme-linked immunosorbent assays (ELISA)-based rotavirus detection showed substantial discordance with polymerase chain reaction-based TaqMan Array Card (TAC) testing: 20.1% of ELISA-negative cases tested TAC-positive, whereas 19.5% of ELISA-positive cases tested TAC-negative. The existing methods handling exposure measurement error usually require that the mismeasurement distribution is known or can be estimated from a subset of study subjects with validated exposure statuses. This condition, however, is often violated when the mismeasurement mechanism is complex. In this article, we develop a novel method for estimating average causal effect using samples with exposures subject to misclassification and limited validation subsamples with correctly ascertained exposures. Our method does not require making any modeling assumptions about exposure mismeasurement. We establish some large-sample properties for the proposed method, based on which statistical inference can be easily carried out. The superiority of our proposed estimator is illustrated through extensive simulation studies. Our proposed estimator is shown to achieve a 39%–53% reduction in variance over the estimator relying solely on validation data in our simulation situations. In the application to the Global Enteric Multicenter Study, the proposed method reveals a substantial adjustment of pathogen-specific diarrhea associations that were previously distorted by inaccurate diagnoses.
Biometrika Other · 发表于 2026-11-10
Hengjia Fang, Wei Ma
摘要
Summary: The biased coin has long been a central device in covariate-adaptive randomization: an imbalance measure is defined, and the next assignment is biased toward the treatment that improves balance. Although this biased coin minimization paradigm is highly effective under equal allocation, its natural extensions to unequal allocation can cause a shift problem, where additional covariate imbalances are not centered at zero. We propose a new covariate-adaptive randomization procedure that moves beyond this paradigm by designing the allocation function directly. The resulting procedure achieves strong marginal balance for covariates used in allocation and eliminates the shift asymptotically for additional covariates. The allocation form is derived from a mechanism analysis of the shift problem and its elimination. An explicit variance formula further reveals favorable variability in additional covariate imbalance.
SiM Bayesian Methods · 发表于 2026-11-09
Mallory J. Flynn, Paul Gustafson
摘要
Populations of interest are often hidden from data for a variety of reasons, though their magnitude remains important in determining resource allocation and appropriate policy. One popular approach to population size estimation, the multiplier method, is a back‐calculation tool requiring only a marginal subpopulation size and an estimate of the proportion belonging to this subgroup. Another approach is to use Bayesian methods, which are inherently well‐suited to incorporating multiple data sources. However, both methods have their drawbacks. A framework for applying the multiplier method which combines information from several known subpopulations has not yet been established; Bayesian models, though able to incorporate complex dependencies and various data sources, can be difficult for researchers in less technical fields to design and implement. Increasing data collection and linkage across diverse fields suggests accessible methods of estimating population size with synthesized data are needed. We propose an extension to the well‐known multiplier method which is applicable to tree‐structured data, where multiple subpopulations and corresponding proportions combine to generate a population size estimate via the minimum variance estimator. The methodology and resulting estimates are compared with those from a Bayesian hierarchical model, for both simulated and real world data. Subsequent analysis elucidates which data are key to estimation in each method, and examines robustness and feasibility of this new methodology.
SiM Diagnostics & Prediction · 发表于 2026-11-09
Ao Sun, Zhanwang Deng, Jiahui Zhao, Hang Li, Xiao‐Hua Zhou
摘要
In clinical practice, multiple biomarkers are used for disease diagnosis, but their individual accuracies are often suboptimal, with only a few proving directly relevant. Effectively selecting and combining biomarkers can significantly improve diagnostic accuracy. Existing methods often optimize metrics like the Area Under the ROC Curve (AUC) or the Youden index. However, optimizing AUC does not yield estimates for optimal cutoff values, and the Youden index assumes equal weighting of sensitivity and specificity, which may not reflect clinical priorities where these metrics are weighted differently. This highlights the need for methods that can flexibly accommodate such requirements. In this article, we present a novel framework for selecting and combining biomarkers to maximize a weighted version of the Youden index. We introduce a smoothed estimator based on the weighted Youden index and propose a penalized version using the SCAD penalty to enhance variable selection. To handle the non‐convexity of the objective function and the non‐smoothness of the penalty, we develop an efficient algorithm, also applicable to other non‐convex optimization problems. Simulation studies demonstrate the performance and efficiency of our method, and we apply it to construct a diagnostic scale for dermatitis.
SiM Bayesian Methods Survival Analysis · 发表于 2026-11-09
Hao Chen, Clara Grazian
摘要
Competing‐risks prediction requires validation methods that assess predictive support for both event time and event type. This is difficult for cause‐specific hazard models because out‐of‐sample log‐scores require positive, well‐defined hazards over the validation horizon, and rare event causes can lead to unstable cause‐specific estimates. We develop the Bayesian hierarchical piecewise‐exponential cause‐specific hazards model (), a competing‐risks model designed for posterior predictive validation using cross‐validated log‐scores. The model specifies positive piecewise‐exponential baseline hazards for each cause and places hierarchical priors on cause‐specific regression coefficients, allowing covariate effects to borrow information across causes while retaining cause‐specific interpretation. Predictive performance is evaluated using cross‐validated posterior predictive log‐scores under the cause‐specific hazards representation. Simulation studies show that the Bayesian piecewise‐exponential framework improves out‐of‐sample predictive support and model‐selection performance across settings with varying signal strength, sample size, censoring, cause imbalance, and cross‐cause heterogeneity. Hierarchical pooling provides the largest benefit when cross‐cause heterogeneity is low to moderate, event causes are imbalanced, or information for rare causes is limited. When true cause‐specific effects are highly heterogeneous, the advantage of partial pooling diminishes, reflecting the expected bias–variance trade‐off. A Surveillance, Epidemiology, and End Results (SEER) colorectal cancer application further demonstrates the practical utility of the method: the treatment‐extended specification evaluated with achieves the best predictive performance, and hierarchical pooling narrows posterior credible intervals for selected rare‐cause coefficients. These findings support as a stable Bayesian posterior predictive framework for imbalanced multi‐cause competing‐risks prediction.
SiM Machine Learning Diagnostics & Prediction Causal Inference · 发表于 2026-11-09
Zihuan Liu, Xin Huang
摘要
Machine learning (ML) models are increasingly used in precision medicine to predict outcomes, prioritize candidate biomarkers, and support treatment decision‐making. Despite their growing adoption, clinical interpretability remains challenging because different optimization objectives correspond to distinct statistical estimands, while post hoc explanation methods often produce complex outputs that are difficult for nontechnical users to interpret. Therefore, frameworks are needed to clarify what model outputs represent and translate technical explanations into clinically meaningful language. To demonstrate how clinical practitioners can select appropriate models, loss functions, and interpretability techniques, we present a tutorial designed to enhance the interpretability of supervised ML models in clinical settings. Our framework integrates feature attribution methods with large language models (LLMs). We first clarify how commonly used loss functions define distinct clinical objectives, ranging from prognostic outcome prediction to individualized treatment rule (ITR) estimation. We then introduce SHapley Additive exPlanations (SHAP) and local interpretable model‐agnostic explanations (LIME) as complementary approaches for global and local interpretation, illustrating how their visualizations summarize model‐based feature contributions. To reduce the programming burden of implementing end‐to‐end ML workflows, we develop an interactive Shiny application that guides users through data input, model training, feature attribution, and LLM‐assisted interpretation. Once installed and configured, users can perform these analyses through a graphical interface without writing analysis code. LLMs serve as an interpretation layer that translates model objectives, predictions, and SHAP/LIME results into concise, clinically meaningful explanations. We also evaluate the reproducibility, faithfulness, and sensitivity of these LLM‐assisted explanations.
SiM Other · 发表于 2026-11-09
Vasileios E. Papageorgiou, Georgios Vasiliadis
摘要
Epidemic waves are often shaped by uncertain external drivers, such as environmental variability or behavioral and policy changes, that can randomly amplify or dampen transmission. Capturing this randomness requires models whose dynamics evolve under time‐varying, stochastic influences. In this paper, we introduce a stochastic susceptible–asymptomatic–symptomatic–removed (SuASR) framework that embeds random external factors directly into the epidemic mechanism through an extended continuous‐time Markov chain (CTMC). The proposed framework is flexible enough to represent epidemic dynamics both with reinfection and with infection‐induced immunity, depending on the epidemiological setting under study. Unlike standard Markovian epidemic models, our formulation explicitly tracks two concurrent infectious sources (asymptomatic and symptomatic), yielding coupled infection pathways and substantially richer transient behavior. A key contribution is analytical tractability, where we derive computable expressions for the joint distribution of asymptomatic and symptomatic infection‐event counts and develop tools tailored to extreme‐outbreak risk, including the distribution of the maximum infectious burden. These results enable probabilistic quantification of epidemic severity beyond mean trajectories, providing direct estimates of the likelihood of rare but consequential surges. We validate the model through an extensive sensitivity analysis and an application to the H1N1 influenza epidemic, illustrating how stochastic external influences reshape outbreak profiles, total infections from both sources, and the probability of extreme epidemic scenarios.
SiM Genetics & Omics Causal Inference · 发表于 2026-11-08
Jia‐Hao Mai, Shun Zhang, Qiu‐Wen Zhu, Wei‐Ying Zhou, Yang Zhang, Jun‐Da Yu, Ji‐Yuan Zhou
摘要
Mendelian randomization (MR) using genome‐wide association study (GWAS) summary statistics is widely used for causal inference. However, conventional MR methods relying on population‐based GWAS are vulnerable to biases arising from family‐level confounders. While family‐based GWAS (FGWAS) designs offer a solution to address these effects, existing MR methodologies are not optimized for the unique structure of FGWAS data, often resulting in reduced statistical power. Therefore, in this paper, we propose the MRcML‐Family (MR based on constrained maximum likelihood for families), a novel method specifically tailored for FGWAS summary statistics. The core innovation of MRcML‐Family lies in its unified framework which simultaneously integrates genetic information from offspring (direct effects) and parents (indirect effects) as instrumental variables. By applying different constraints, the method effectively identifies and corrects for horizontal pleiotropy. Comprehensive simulation studies demonstrate that MRcML‐Family yields nearly unbiased causal estimates and maintains robust Type I error rate control whether or not the instrument strength independent of direct effect assumption holds, even in challenging scenarios with a limited number of SNPs and small FGWAS sample sizes. Furthermore, real‐world data analyses using UK Biobank data show that MRcML‐Family provides causal estimates highly consistent with existing literature and recovers the established “gold standard” relationship between height and body mass index. Additionally, it showed higher statistical power than the compared methods in the evaluated scenarios, mitigating the efficiency loss typically associated with family‐based designs.
JASA Other · 发表于 2026-11-06
Shota Takeishi, Shonosuke Sugasawa
摘要
Cross-classified data frequently arise in scientific fields such as education, healthcare, and social sciences. A common modeling strategy is to introduce crossed random effects within a regression framework. However, this approach often encounters serious computational bottlenecks, particularly for non-Gaussian outcomes. In this paper, we propose a scalable and flexible method that approximates the distribution of each random effect by a discrete distribution, effectively partitioning the random effects into a finite number of representative values. This approximation allows us to express the model as a multi-way discrete structure, which can be efficiently estimated using a simple and fast iterative algorithm. The proposed method accommodates a wide range of outcome models and remains applicable even in settings with more than two-way cross-classification. We theoretically establish the consistency and asymptotic normality of the estimator under general settings of classification levels. Through simulation studies and real data applications, we demonstrate the practical performance of the proposed method in logistic, Poisson, and ordered probit regression models involving cross-classified structures.
Biometrika Other · 发表于 2026-11-06
Jiaji Su, Zhigang Yao
摘要
Summary: Over the past decades, the increasing dimensionality of data has increased the need for effective data decomposition methods. Existing approaches, however, often rely on linear models or lack sufficient interpretability or flexibility. To address this issue, we introduce a novel nonlinear decomposition technique called the principal nested submanifolds, which builds on the foundational concepts of principal component analysis. This method exploits the local geometric information of data sets by projecting samples onto a series of nested principal submanifolds with progressively decreasing dimensions. It effectively isolates complex information within the data in a backward stepwise manner by targeting variations associated with smaller eigenvalues in local covariance matrices. The fitted structures are smooth nested manifolds rather than linear or special-shape subspaces. Simulation studies and an analysis of single-cell RNA-sequencing data illustrate how the method summarizes locally varying nonlinear structure while retaining a compatible hierarchy across dimensions. It provides flexible subspace constraints that facilitate the extraction of data components and noise reduction. This approach advances the non-Euclidean statistical analysis of data with low-dimensional intrinsic structure within Euclidean spaces and offers a complementary perspective for high-dimensional noisy data sets in fields such as bioinformatics and machine learning.
Biometrics Causal Inference Survival Analysis Nonparametric & Semiparametric · 发表于 2026-11-06
Rui Hu, Ted Westling
摘要
In observational studies, the observed association between an exposure and outcome of interest may be distorted by unobserved confounding. Causal sensitivity analysis can be used to assess the robustness of observed associations to potential unobserved confounding. For time-to-event outcomes, existing sensitivity analysis methods rely on parametric assumptions on the structure of the unobserved confounders and Cox proportional hazards models for the outcome regression. If these assumptions fail to hold, it is unclear whether the conclusions of the sensitivity analysis remain valid. Additionally, causal interpretation of the hazard ratio is challenging. To address these limitations, in this paper, we develop a nonparametric sensitivity analysis framework for time-to-event data. Specifically, we derive nonparametric bounds for the difference between the observed and counterfactual survival curves and propose estimators and inference for these bounds using semiparametric efficiency theory. We also provide nonparametric bounds and inference for the difference between the observed and counterfactual restricted mean survival times. We demonstrate the performance of our proposed methods using numerical studies and an analysis of the causal effect of elective neck dissection on mortality in patients with high-grade parotid carcinoma.
Biometrics Latent Variables & Mixtures Networks & Graphs · 发表于 2026-11-06
Nandini Dendukuri, Ian Schiller, Else Margreet Bijker, Michael Libman, Paul Gustafson, Patrick M Bossuyt, Joanna Merckx
摘要
In the absence of a perfect diagnostic test for a target condition, one or more imperfect tests may be used to arrive at a clinical diagnosis. Latent class analysis can be used to model data from imperfect tests with the objective of estimating test accuracy and target condition prevalence. Such models typically assume there are 2 latent classes underlying the observed data—target condition positive and target condition negative. However, as we illustrate, this would be an oversimplification when any of the observed tests has a measurand that is different from the target condition. We show how a directed acyclic graph can be used to illustrate the relationships between the relevant variables—the observed imperfect test results, their latent measurands, the latent target condition, covariates affecting observed or latent variables, and sources of conditional dependence. We then show how to determine the underlying latent classes and their labels. Finally, we examine how consideration of the measurand of each test impacts the likelihood and identifiability of the latent class model. Using simulation studies, we show how ignoring measurands, which are distinct from the target condition, can lead to mislabeling of the latent classes. We illustrate the value of the proposed approach by re-analyzing 2 datasets used in previously published latent class analyses of tests for pediatric tuberculosis and leptospirosis.
SMMR Causal Inference · 发表于 2026-11-06
Amir Aamodt Kazemi, Joseph Sexton, Inge Christoffer Olsen
摘要
Instrumental variable (IV) methods are widely used to address unmeasured confounding in observational studies but typically estimate the local average treatment effect (LATE) for compliers. If there exist effect modifying variables that also affect the choice of treatment, the LATE may have limited clinical relevance. To address this limitation, we propose a novel framework for estimating the conditional average treatment effect (CATE) for a categorical treatment variable in the presence of both observed confounding and effect-modifying variables in addition to valid IVs. Building on recent developments in data fusion between randomized trial and observational data, we combine IV estimators with estimators based on covariate adjustment. By making parametric assumptions about the residual unobserved confounding effect, we obtain a consistent estimator of the CATE with relatively high efficiency. In a simulation study with nonlinear effect modification and unobserved confounding, we show that our estimator outperforms competing IV and covariate-adjusted estimators in terms of mean squared error. We further illustrate the applicability of the method, utilizing it to compare tumor necrosis factor alpha inhibitors as the first line biologic treatment of rheumatoid arthritis conditional on age. The analysis illustrates how the proposed method can estimate population-relevant, clinically interpretable treatment effects and suggests smaller differences between treatments among older patients. This work provides a general framework for combining instrumental and confounding information to estimate individualized causal effects when treatment effects are heterogeneous and there are more than two treatment alternatives.
Biometrika Other · 发表于 2026-11-05
M Chak, Z F Rico, G Zanella
摘要
Summary: We show that strong log-concavity emerges in probit regression likelihoods without ridge penalization (i.e. Gaussian priors), unlike for the logistic case. Specifically, we provide: (a) a non-asymptotic characterization of strong log-concavity for fixed designs, similar to that for the existence of the maximum likelihood estimator (MLE) and (b) an asymptotic analysis for random designs, in the proportional regime when the sample size 𝑛 and the number of covariates 𝑑 grow proportionally d/𝑛 → 𝑟 ∈ [0, 1). In the latter case we show that, provided r is small enough, the resulting condition number is finite and bounded independently of 𝑛, d, r with high-probability. Numerically tractable estimates are given in case r = 0. Thus, probit regression provides a non-trivial example of a high-dimensional, well-conditioned log-concave objective.
SMMR Survival Analysis Causal Inference · 发表于 2026-11-05,收录于 2026-11-06
Maria Veronica Vinattieri, Laura Buschmann, Jürgen Wellmann, André Karch, Heike Minnerup, Keith Humphreys
摘要
Self-selection bias in observational studies assessing the effectiveness of a breast cancer screening program can arise when non-participants of screening have worse general health conditions or lower compliance with treatments than screening participants. Building on recently described methodology for tumour progression modelling and causal survival analysis of screening data, our main contribution is to describe approaches to conduct sensitivity analyses for self-selection effects when studying screening effects on all-cause survival and breast cancer cumulative incidence, among screen-detected cases, in a population where all individuals are offered screening. Sensitivity analyses are inspired by an approach to correcting for self-selection bias that has been used for observational studies of mortality. We report simulation studies that demonstrate the impact that a correction factor has on all-cause survival and on the cumulative incidence of breast cancer death following diagnosis. We also apply our methods to estimate the benefit of early detection in non-overdiagnosed screen-detected cancers using data from the German mammography screening program. For sensitivity parameter values, we leverage on data on other (non-breast cancer) cause survival among participants and non-participants of mammography screening in the same study and estimate how counterfactual all-cause survival is improved, and breast cancer cumulative incidence is reduced for patients with screen-detected cancers, when accounting for self-selection bias.
Biometrics Latent Variables & Mixtures · 发表于 2026-11-04,收录于 2026-11-06
Francis K C Hui, Patricia Menéndez, Scott Foster, Skip Woolley
摘要
When modeling species assemblages in ecology, clustering species with similar environmental responses can facilitate a more parsimonious understanding of species compositions and improve the prediction of the overall community. One statistical method that implements this idea is species archetype models (SAMs), a type of finite mixture of regression model where species are grouped according to the shape of their environmental response. However, a current shortcoming of SAMs is their computational complexity, hindering their usefulness in cases involving hundreds or thousands of sites and/or species. In this paper, we propose approximate and scalable SAMs (asSAMs) to overcome this drawback. The key to asSAMs lies in constructing a quadratic approximation to individual species-archetype contributions to the marginal likelihood. This results in an objective function resembling a finite mixture of multivariate normal densities, which can be maximized via fully closed-form iterative updates. We demonstrate how asSAMs also promote fast uncertainty quantification using bootstrapping, and variable selection through an additional regularization penalty. Simulation studies and an application to presence-absence records of over 230 species from the Great Barrier Reef Seabed biodiversity project demonstrate that asSAMs can achieve strong estimation, selection, and predictive performance, while being computationally much faster than current methods for fitting SAMs. This makes asSAMs a practical approach for clustering species' environmental responses in high-dimensional species assemblage datasets.
Biometrics Survival Analysis Testing & Uncertainty Missing Data & Measurement Error · 发表于 2026-11-04,收录于 2026-11-06
Giorgos Bakoyannis, Aristofanis Rontogiannis, Ying Zhang, Wanzhu Tu, Ann Mwangi, Constantin T Yiannoutsos
摘要
Analysis of competing risks data is often complicated by incomplete or selectively missing information on the cause of failure. Standard approaches typically assume that the cause of failure is missing at random (MAR), an assumption that is generally untestable and frequently implausible in observational studies. We propose a novel sensitivity analysis framework for the proportional cause-specific hazards model that accommodates missing-not-at-random (MNAR) scenarios. A sensitivity parameter is used to quantify the association between missingness and the unobserved cause of failure. Regression coefficients are estimated as functions of this parameter, and a simultaneous confidence band is constructed via a wild bootstrap procedure. This allows identification of a range of MNAR scenarios for which effects remain statistically significant; we refer to this range as a robustness interval. The validity of the proposed approach is justified both theoretically, via empirical process theory, and empirically, through simulation studies. We apply the method to the analysis of data from an HIV cohort study in sub-Saharan Africa, where a substantial proportion of causes of failure are missing and the MAR assumption is implausible. The analysis shows that key findings regarding risk factors for care interruption and mortality are robust across a broad spectrum of MNAR scenarios, underscoring the method's utility in situations with MNAR causes of failure.
SMMR Survival Analysis Meta-Analysis & Data Integration · 发表于 2026-11-04,收录于 2026-11-06
Chaoqi Wang, Jie Ding, Xiaoguang Wang
摘要
Limited sample sizes can impair the statistical accuracy of traditional survival models, resulting in potentially unsatisfactory conclusions. To address this issue, we propose a robust transfer learning framework for the accelerated failure time model (RTrans-AFT) that enables efficient and flexible information borrowing from an external source. The method accommodates both individual-level and summary-level source data and models differences in regression coefficients between cohorts without requiring identical covariate distributions. To control the degree of transfer, we impose an adaptive lasso penalty to control the discrepancy between the source and target parameters. This allows the method to selectively borrow information from the source cohort in the presence of heterogeneity, while fully incorporating external information when the two cohorts are comparable. Importantly, the framework is robust to potential data irregularities, such as outliers, which are common in real-world survival datasets. We establish the consistency and asymptotic normality of the proposed estimator. Simulation studies demonstrate that RTrans-AFT substantially improves estimation accuracy and achieves notable variance reduction, leading to enhanced statistical efficiency. The practical utility of the method is further illustrated through an analysis of lung adenocarcinoma data, where the Surveillance, Epidemiology, and End Results (SEER) registry data serve as the external source.
SiM High-Dimensional Causal Inference Testing & Uncertainty · 发表于 2026-11-04,收录于 2026-11-06
Zixuan Zhao, Yuehan Yang
摘要
We propose a design-based covariate adjustment that leverages information from auxiliary strata to improve the efficiency of average treatment effect estimation when target samples are sparse. The estimator borrows strength from related strata that may be correlated with the target, yielding gains for studies with limited observations or rare subpopulations. We present the estimator, develop a Neyman-style conservative variance estimator for hypothesis testing and confidence interval construction, and establish its large-sample properties. The procedure is straightforward to implement within standard randomization-based workflows and does not require a correctly specified outcome model or stochastic error assumptions. In simulations, the method delivers lower variance and narrower confidence intervals than conventional design-based or regression-adjusted estimators across a range of sparsity and correlation patterns. Applications to a schooling experiment and the ACTG 175 randomized trial illustrate practical gains in precision.
Biometrics Other · 发表于 2026-11-04,收录于 2026-11-06
Nikolai Spuck, Ingo Gräff, Moritz Berger
摘要
The proportional odds model is arguably the most widely applied regression approach for ordinal response variables. It assumes that the effects of the covariates are constant across the response categories allowing a parsimonious model specification. A violation of this assumption, however, may lead to biased effect estimates and decreased predictive ability. To overcome this issue, partial proportional odds models, where proportionality is only enforced for a smaller subset of covariates, can be applied. While statistical tests to check the proportional odds assumption are available, a generalized framework for data-driven selection of category-specific effects has not been established. In this paper, we introduce a novel tree-structured algorithm that forms clusters of categories sharing the same effect on the ordinal response, with a focus on model parsimony and ease of interpretation. The proposed model appeared to be superior to alternatives in a clinical application to data from the University Hospital Bonn on patients presenting in the emergency department. The predictive ability and selection properties of the proposed approach were also compared to alternative approaches, such as LASSO-penalized regression, in a simulation study.
Biometrics Other · 发表于 2026-11-04,收录于 2026-11-06
Xinjie Zhou, Zhengbang Li
摘要
Quantifying how the predictive value of biomarkers varies across patient characteristics is central to precision medicine. While Individual Variable Importance (IVI) offers a rigorous framework for this task, existing non-parametric estimators often prove unstable and inefficient in clinical studies with limited sample sizes ($N\lt 500$). To address this, we propose a Linear Projection IVI framework that prioritizes inferential stability over functional flexibility. We formulate the estimator as a first-order approximation to high-dimensional importance surfaces using linear interaction structures. Theoretical results establish that, even under model misspecification, the estimator converges to a well-defined pseudo-true parameter corresponding to the best linear projection of the underlying IVI function. We derive closed-form expressions for local and global importance, prove $\sqrt{N}$-consistency, and introduce a principled "Gatekeeper" hypothesis test. This procedure utilizes a robust joint Wald statistic to control Type I error for heterogeneity detection prior to subgroup stratification, effectively preventing spurious discovery. Simulation studies demonstrate superior finite-sample efficiency relative to kernel-based alternatives and robustness to binary outcome misspecification. Applications to NHANES and Pima Indian diabetes datasets illustrate the framework's utility in distinguishing reproducible biological signals from noise in data-constrained settings.
SMMR Bayesian Methods High-Dimensional Genetics & Omics · 发表于 2026-11-04,收录于 2026-11-06
Jingxiong Xu, Nanwei Wang, Yonathan Brhane, Christopher I Amos, Laurent Briollais
摘要
A common approach for detecting rare variants (RVs) associated with complex human diseases is to perform a gene-based analysis or a region-based test of association. Typically, in a gene-based analysis, all the RVs pertaining to the gene considered are included in the statistical test, which potentially reduces its power since most RVs are likely not associated with the outcome of interest. As paradigm shift, we propose to add a variable selection step to choose the RVs that compose the gene-based test statistic as a way to enhance the power of the test. We propose a Bayes factor (BF) test statistic derived from the generalized linear model and its conjugate prior. A key component of our approach is the selection of the important RVs within a gene, which is performed through a birth-death Markov Chain Monte Carlo algorithm. Our approach can also leverage functional annotation at the RV level through the elicitation of the conjugate prior. Through simulation studies, we show that the proposed BF outperformed competing approaches both in terms of gene ranking and power to detect gene-based associations. The power of BF was improved by the use of the variable selection procedure and this gain of power was more substantial when functional annotation was included in this procedure. The application of our new approach to a large whole-exome sequencing data set comparing 1658 individuals with lung cancer to 1492 healthy controls was able to identify new genes associated with lung cancer and pointed towards interesting cancer-related pathways.
SMMR Clinical Trials Bayesian Methods · 发表于 2026-11-04,收录于 2026-11-06
Yeonhee Park
摘要
Incorporating historical data into clinical trials can enhance statistical power, but it risks introducing bias if historical and current populations differ. Existing Bayesian borrowing methods often apply a single, prespecified weight to historical data, failing to account for patient-level covariate differences. To address this, we propose a covariate-adjusted self-adapting mixture (CASAM) prior, a Bayesian framework that enables covariate-dependent dynamic borrowing from external data. CASAM adaptively determines the degree of information borrowing by assessing the compatibility between historical and current data conditional on covariates, automatically down-weighting historical information when residual heterogeneity is detected. To further address covariate distribution mismatch between historical and current trials, we develop a propensity-score-integrated implementation of CASAM, which first re-weights historical controls to align their covariate distribution with that of the current control arm before applying the CASAM prior. This layered strategy allows CASAM to focus on structural similarity while the propensity-score adjustment corrects for population-level imbalance. Together, CASAM and its propensity-score-based implementation provide an empirical-Bayes framework for adaptive borrowing that combines covariate alignment with outcome-model compatibility assessment.
Biometrics Latent Variables & Mixtures Genetics & Omics · 发表于 2026-11-04,收录于 2026-11-06
Zhongmao Liu, Xiaohui Yin, Yanjiao Zhou, Gen Li, Kun Chen
摘要
In microbiome studies, it is often of great interest to identify clusters or partitions of microbiome profiles within a study population and to characterize the distinctive attributes of each resulting microbial community. While raw counts or relative compositions are commonly used for such analysis, variations between clusters may be driven or distorted by subject-level covariates, reflecting underlying biological and clinical heterogeneity across individuals. Simultaneously detecting latent communities and identifying covariates that differentiate them can enhance our understanding of the microbiome and its association with health outcomes. To this end, we propose a Dirichlet-multinomial mixture regression (DMMR) model that enables joint clustering of microbiome profiles while accounting for covariates with either homogeneous or heterogeneous effects across clusters. A novel symmetric link function is introduced to facilitate covariate modeling through the compositional parameters. We develop efficient algorithms with convergence guarantees for parameter estimation and establish theoretical properties of the proposed estimators. Extensive simulation studies demonstrate the effectiveness of the method in clustering, feature selection, and heterogeneity detection. We illustrate the utility of DMMR through a comprehensive application to upper-airway microbiota data from a pediatric asthma study, uncovering distinct microbial subtypes and their associations with clinical characteristics.
SiM Causal Inference · 发表于 2026-11-04,收录于 2026-11-06
S M Hasan Ul Bari, Marshia Rahman
摘要
No new empirical data were generated. The simulation code (Python) that reproduces Table 1, Figure 1, and Supporting Figure S1 is provided as Supporting Information. Figure S1: Rejection rates (α = 0.05) of the joint Wald test of the five leads, the time-shifted placebo (Periods 4–6 vs. 1–3), and the negative control outcome DiD, as the size of each violation increases. (a) Linear differential drift of 0 to 0.30 error standard deviations per period (Scenario B). (b) Shock coinciding with the policy of 0 to 1.5 error standard deviations (Scenario C). The x-axis shows the resulting bias of the main DiD estimate. Same design as Table 1 (50 units, 25 treated, 10 periods, policy from Period 7, AR(1) errors with ρ = 0.5); 2000 replications per point. The negative control outcome receives the shock in (b) but no drift in (a). In (a), bias = 5 × drift per period (drift 0 to 0.30). The dashed line marks the nominal 5% level; in (b) the two pre-period diagnostics overlap at this level (4.3% to 5.4%). Monte Carlo standard error ≤ 0.011. Supplementary S1: Data S1: Python simulation code reproducing Table 1, Figure 1, and Figure S1. Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article. *(abstract via OpenAlex)*
Biometrics Bayesian Methods · 发表于 2026-11-04,收录于 2026-11-06
Haoyu Wu, David A Stephens, Erica E M Moodie
摘要
Statistical modeling of infectious disease outbreaks with incidence data is crucial to understanding epidemic dynamics and informing public health interventions. Stochastic epidemic models (SEMs) account for the inherent stochasticity in epidemic evolution and are particularly useful in small outbreaks or low-prevalence settings. In SEMs, the epidemic is naturally represented as a continuous-time Markov jump process (MJP), while surveillance data are collected at discrete times and subject to underdetection. Fitting SEMs to partially observed epidemic trajectories requires integrating over all possible transition paths, which is often intractable. Individual-level data augmentation (DA) methods have been developed to address these challenges. However, existing approaches either rely on per-subject updates with limited scalability or impose typically unrealistic assumptions to simplify the complex dimensional change problem for state-space SEMs. We present an efficient DA Markov chain Monte Carlo (MCMC) framework for fitting continuous-time state-space SEMs to incidence data. Our method uses a block sampler to jointly update individual trajectories and proposes transition times using a discrete-time approximation to the latent MJP. Through simulation studies, we demonstrate that our method significantly improves MCMC mixing and scalability compared to the previous DA approach and remains computationally robust in scenarios where particle MCMC algorithms struggle. We apply the method to the 2014 Ebola outbreak in a rural village in Sierra Leone and the 2009 H1N1 outbreak in a remote community in Canada.
JASA Testing & Uncertainty · 发表于 2026-11-04,收录于 2026-11-06
Yu Gui, Ying Jin, Yash Nair, Zhimei Ren
摘要
This paper presents adaptive conformal selection (ACS), an interactive framework for model-free selection with guaranteed error control. Building on conformal selection (Jin and Candès, 2023b), ACS generalizes the approach to support human-in-the-loop adaptive data analysis. Under the ACS framework, we can partially reuse the data to boost the selection power, make decisions on the fly while exploring the data, and incorporate new information or preferences as they arise. The key to ACS is a carefully designed principle that controls the information available for decision making, allowing the data analyst to explore the data adaptively while maintaining rigorous control of the false discovery rate (FDR). Based on the ACS framework, we provide concrete selection algorithms for various goals, including model update/selection, diversified selection, and incorporating newly available labeled data. The effectiveness of ACS is demonstrated through extensive numerical simulations and real-data applications in large language model (LLM) deployment and drug discovery. *(abstract via OpenAlex)*